Salivary and urinary diagnosis of human immunodeficiency viruses 1 and 2 infection in Côte d'Ivoire, using two assays

Abstract

This investigation, done at the Institut Pasteur de Cote d'Ivoire ‘blind’ of the previous serological findings, suggests that gacelisa, a commercial immunoglobulin G capture enzyme immunoassay for anti-human immunodeficiency virus antibody, can be successfully applied to unprocessed saliva and urine specimens. Its accuracy may be as high as that of conventional enzyme assays on serum tested under similar conditions. However, the role of gacpat, a similar assay, as a cheap alternative screening test for urine remains in doubt unless its non-specificity can be controlled.